Now showing items 1-1 of 1

  • Gombos, A.; Goncalves, A.; Curigliano, G.; Bartsch, R.; Kyte, Jon A; Ignatiadis, M.; Awada, A. (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2023)
    Estrogen receptor-positive (ER+)/HER2-negative (HER2−), the so-called luminal-type breast cancer, is the most frequent subset, accounting for around 70% of all breast cancer cases. Endocrine therapy (ET) combined with ...